TEXAS DEPARTMENT OF STATE HEALTH SERVICES Infectious Disease Control Unit Epi Case Criteria Guide, 2019 Revision date: January 2019 Texas Department of State Health Services Epi Case Criteria Guide, 2019 Editor Laura Tabony, MPH Contributors Adam Lynch, MPH Jonathan Kolsin, MPH Amy Littman, B.A Kamesha Owens, MPH Anna Nutt, MPH, CIC Kelly Broussard, MPH Bobbiejean Garcia, MPH, CIC Laura Robinson, DVM, MS Bonny Mayes, MA Melba Zambrano, MSN, RN, CIC Briana O’Sullivan, MPH Rachael Straver, DVM, MPH Eric Garza, MPH Sandi Arnold, RN, CIC Greg Leos, MPH, CPH Sepehr Arshadmansab, MPH Hailey Rucas, MPH Thi Dang, MPH, CIC Johnathan Ledbetter, MPH Vivienne Heines, MPH, CPH Texas Department of State Health Services Infectious Disease Control Unit Emerging and Acute Infectious Disease Branch//Zoonosis Control Branch Mail Code 1960 PO Box 149347 Austin, TX 78714-9347 Phone 512.776.7676 • Fax 512.776.7616 Revised: January 2019 Publication No. E59-11841 Revision date: January 2019 ~ ii REVISIONS MADE FROM THE 2018 TO THE 2019 EPI CASE CRITERIA GUIDE Changes in scope/name . Salmonellosis to Salmonella Paratyphi and Salmonellosis, non-Paratyphi/non-Typhi . Typhoid Fever to Salmonella Typhi Revisions of case Criteria for Confirmed, Probable, or Suspect cases (CC, PC, SC), Clinical Description and/or criteria (CD), Laboratory Confirmation tests (LC) and Note(s) (N) . Anthrax ........................................................................................................ LC, N . Prion diseases such as Creutzfeldt-Jakob disease (CJD) .. CC, PC, CD, LC, N . Arbovirus, neuroinvasive and non-neuroinvasive ........................ CC, CD, LC, N . Rickettsiosis, unspecified ...................................................................... PC, LC, N . Carbapenem-resistant Enterobacteriaceae (CRE)...................... CC, PC, LC, N . Typhoid Fever/Salmonella Typhi ..................................................... PC, CD, N . Chagas disease, acute ................................................................... CC, PC, LC, N . Spotted fever group rickettsioses .......................................................... PC, LC, N . Chagas disease, chronic indeterminate ...................................................... PC, N . Tularemia ...................................................................................................... PC, N . Chagas disease, chronic symptomatic ....................................................... PC, N . Typhus, flea-borne (endemic, murine) ................................................. PC, LC, N . Cysticercosis ................................................................................................ LC, N . Typhus fever (epidemic, louse-borne) ................................................. PC, LC, N . Diphtheria .................................................................................... CC, CD, LC, N . Viral hemorrhagic fever (VHF) Non-Ebola ............................................. SC, LC . Ebola (HF) ................................................................................................ SC, LC . Yellow fever ....................................................................................... PC, CD, LC . Hepatitis A, acute ........................................................................ CC, CD, LC, N . Yersiniosis .......................................................................................................... PC . Hookworm (ancylostomiasis) ......................................................................... LC . Zika disease, congenital .................................................................................... LC . Listeriosis ...................................................................................... PC, SC, LC, N . Zika disease, non-congenital ..................................................................... CD, LC . Lyme disease ............................................................................................... PC, N . Zika infection, congenital .................................................................................. LC . Multidrug-resistant Acinetobacter (MDR-A) ........................................ CD, LC . Zika infection, non-congenital ................................................................... PC, LC Revision date: January 2019 ~ iii ~ TABLE OF CONTENTS This document provides infectious disease information for surveillance and data entry staff. It contains a table with condition codes, condition names, and case criteria to aid in the classification and coding of conditions. It is organized alphabetically by condition name. Conditions specified as reportable in Title 25, Texas Administrative Code, Chapter 97, Subchapter A, Control of Communicable Diseases are in bold type. Click on a condition in the table of contents to go to the text and on the condition code to move back. Editor .............................................................................................................................................................................................................................................. ii Contributors ................................................................................................................................................................................................................................. ii REVISIONS MADE FROM THE 2018 TO THE 2019 EPI CASE CRITERIA GUIDE ......................................................... ii Table of Contents ........................................................................................................................................................................... iv Definition of Terms ....................................................................................................................................................................... vii Abbreviations ................................................................................................................................................................................ viii Notes ................................................................................................................................................................................................ ix CASE CRITERIA ............................................................................................................................................................................... 10 Acute Flaccid Myelitis ..................................................................................................................................................................................................................................................................................... 10 Amebiasis .............................................................................................................................................................................................................................................................................................................. 10 Am Amebic meningitis/encephalitis, other................................................................................................................................................................................................................................................ 11 Amebic meningoencephalitis, primary (PAM) ............................................................................................................................................................................................................................. 12 Anaplasma phagocytophilum .................................................................................................................................................................................................................................................................... 12 Anthrax .................................................................................................................................................................................................................................................................................................................. 13 Arbovirus, neuroinvasive (encephalitis/meningitis) and non-neuroinvasive ............................................................................................................................................................. 14 Ascariasis .............................................................................................................................................................................................................................................................................................................. 15 Ba Babesiosis .............................................................................................................................................................................................................................................................................................................. 16 Botulism, foodborne....................................................................................................................................................................................................................................................................................... 17 Botulism, infant................................................................................................................................................................................................................................................................................................